ADVFN - ニュース

S&P 500

5,431.60

0.00%

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/17	21 : 36	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:ALLG	Allego NV
2024/06/17	21 : 36	PR Newswire (US)	Raya Therapeutic Announces Supportive Clinical Results of Fasudil (RT1968) in ALS Patients
2024/06/17	21 : 36	PR Newswire (Canada)	Raya Therapeutic Announces Supportive Clinical Results of Fasudil (RT1968) in ALS Patients
2024/06/17	21 : 36	PR Newswire (US)	CH4 Global and CirPro Australia announce successful processing of first cattle to be fed Methane Tamer™ at commercial scale
2024/06/17	21 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/06/17	21 : 35	Business Wire	Beyond, Inc. Announces Structural Leadership Changes	NYSE:BYON	Beyond Inc
2024/06/17	21 : 35	GlobeNewswire Inc.	Triumph Financial and C.H. Robinson Announce Strategic Relationship	NASDAQ:TFIN	Triumph Financial Inc
2024/06/17	21 : 35	GlobeNewswire Inc.	Triumph Financial and C.H. Robinson Announce Strategic Relationship	NASDAQ:CHRW	CH Robinson Worldwide Inc
2024/06/17	21 : 35	PR Newswire (US)	Production Equipment from Major Stretch-Film Manufacturer Goes to Auction June 26
2024/06/17	21 : 35	PR Newswire (US)	Maxeon to Showcase Latest Solar Energy Innovations and New Panel Technologies at Intersolar Europe 2024	NASDAQ:MAXN	Maxeon Solar Technologies Ltd
2024/06/17	21 : 35	PR Newswire (Canada)	L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - CBST
2024/06/17	21 : 33	Alliance News	Cizzle says CIZ1B biomarker test picked for "major" US cancer study	LSE:CIZ	Cizzle Biotechnology Holdings Plc
2024/06/17	21 : 33	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	AMEX:SCCG	Sachem Capital Corp
2024/06/17	21 : 33	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	USOTC:OHCS	Optimus Healthcare Services Inc (PK)
2024/06/17	21 : 33	PR Newswire (Canada)	Canadian Investment Regulatory Organization Trade Resumption - CBST
2024/06/17	21 : 33	PR Newswire (US)	Prime Jet Celebrates 13 Years of Excellence in Private Aviation
2024/06/17	21 : 33	PR Newswire (US)	Onecent Technology: Pioneering Social Connections in Gaming
2024/06/17	21 : 32	GlobeNewswire Inc.	Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina	NASDAQ:YTEN	Yield10 Bioscience Inc
2024/06/17	21 : 32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CMPX	Compass Therapeutics Inc
2024/06/17	21 : 32	GlobeNewswire Inc.	Aerovate Therapeutics Announces 24-Week Topline Results from the Phase 2b Portion of IMPAHCT Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/06/17	21 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:LNG	Cheniere Energy Inc
2024/06/17	21 : 31	Business Wire	RealPage Showcases AI-Enabled Innovations at Apartmentalize 2024
2024/06/17	21 : 31	PR Newswire (US)	Human8 Releases Fresh Research on How Consumers are Embracing Life and Experiences Amid Chaos
2024/06/17	21 : 31	PR Newswire (US)	365 Connect to Showcase AI-Powered Marketing and Leasing Platform at Apartmentalize Conference in Philadelphia
2024/06/17	21 : 31	PR Newswire (US)	Hi-Tech Pharmaceuticals Forms Joint Ventures to Keep Up With Demand of Berberine Cyclosome® - A Revolutionary Breakthrough in Blood Sugar Metabolism Support and Weight Management
2024/06/17	21 : 30	Edgar (US Regulatory)	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]	NYSE:XYF	X Financial
2024/06/17	21 : 30	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:GANX	Gain Therapeutics Inc
2024/06/17	21 : 30	GlobeNewswire Inc.	P10 Announces Results of its Annual Meeting of Stockholders	NYSE:PX	P10 Inc
2024/06/17	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/06/17	21 : 30	GlobeNewswire Inc.	Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy	NASDAQ:MBIO	Mustang Bio Inc